Lidds AB (Sweden) Today
| LIDDS Stock | SEK 0.12 0.01 7.69% |
Performance4 of 100
| Odds Of DistressLess than 39
|
Lidds AB is selling for under 0.12 as of the 22nd of November 2024; that is 7.69 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.11. Lidds AB has about a 39 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Lidds AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of September 2024 and ending today, the 22nd of November 2024. Click here to learn more.
LIDDS AB develops and sells pharmaceutical products for cancer and other diseases worldwide. It is developing various drugs, such as NZ-2HOF to treat prostate cancer NZ-DTX for lung cancer and solid tumors NZ-DOX for solid tumors NZ-IO, an antibody-based immunotherapy NZ-STING for immuno-oncology and NZ-BELINA for breast cancer. The company has 37.38 M outstanding shares. More on Lidds AB
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lidds Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lidds AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lidds AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Lidds AB (LIDDS) is traded on Stockholm Exchange in Sweden and employs 7 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 56.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lidds AB's market, we take the total number of its shares issued and multiply it by Lidds AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lidds AB operates under Biotechnology sector and is part of Health Care industry. The entity has 37.38 M outstanding shares.
Lidds AB has accumulated about 34 M in cash with (42.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.79, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Lidds AB Probability Of Bankruptcy
Ownership AllocationLidds AB maintains a total of 37.38 Million outstanding shares. Lidds AB secures 18.67 % of its outstanding shares held by insiders and 3.37 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lidds Ownership Details
Lidds AB Risk Profiles
Although Lidds AB's alpha and beta are two of the key measurements used to evaluate Lidds AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 7.55 | |||
| Semi Deviation | 8.9 | |||
| Standard Deviation | 11.62 | |||
| Variance | 134.98 |
Lidds Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lidds AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Lidds AB Corporate Management
Elected by the shareholders, the Lidds AB's board of directors comprises two types of representatives: Lidds AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lidds. The board's role is to monitor Lidds AB's management team and ensure that shareholders' interests are well served. Lidds AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lidds AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jenni Bjornulfson | CFO IR | Profile | |
| Kia Bengtsson | Head Devel | Profile | |
| Matthew Lindon | Chief Officer | Profile | |
| Anders Mansson | Chief Officer | Profile | |
| Monica Wallter | Advisor | Profile | |
| Annette Moldrup | Chief Officer | Profile | |
| Johan MD | Chief Officer | Profile |
Additional Tools for Lidds Stock Analysis
When running Lidds AB's price analysis, check to measure Lidds AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lidds AB is operating at the current time. Most of Lidds AB's value examination focuses on studying past and present price action to predict the probability of Lidds AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lidds AB's price. Additionally, you may evaluate how the addition of Lidds AB to your portfolios can decrease your overall portfolio volatility.